Diacylglycerol acyltransferase inhibitors

US7714126B2 · kind B2 · utility

Assignee

• VIA Pharmaceuticals, Inc. · US

Inventors

• David Robert Bolin · Montclair, US
• Adrian Wai-Hing Cheung · Glen Rock, US
• Fariborz Firooznia · Madison, US
• Matthew Hamilton · Hackettstown, US
• Shiming Li · Glastonbury, US
• Lee Apostle McDermott · Sayreville, US
• Yimin Qian · Plainsboro, US
• Weiya Yun · Richmond, US

Key dates

• Filing date: Nov 17, 2006
• Grant date: May 11, 2010
• Expiry date: Jun 18, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity, type II diabetes mellitus and metabolic syndrome.